Bank of Montreal
CYT

Bank of Montreal’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

Bank of Montreal’s Portfolio CYT Stock Details CYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-66,300
Closed -$204K – 4470
2023
Q4 		$204K Buy
+66,300
New +$201K ﹤0.01% 3129

Other funds holding CYT

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Bank of Montreal's CYT Position: Q1 2024 in Review

Bank of Montreal sold out of Cyteir Therapeutics, Inc. Common Stock (CYT) in Q1 2024, closing a stake of 66,300 shares — an estimated $204K sold.

Bank of Montreal first reported a position in CYT in Q4 2023 and held it in 1 quarter. The position peaked at $204K in Q4 2023. 4 funds tracked by Wall St. Rank hold CYT as of Q1 2024.

  • Bank of Montreal reported no remaining Cyteir Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bank of Montreal sold 66,300 Cyteir Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $204K.
  • Bank of Montreal first reported a position in Cyteir Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Bank of Montreal's Cyteir Therapeutics, Inc. Common Stock position peaked at $204K in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Cyteir Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.